Search Results - "O'Rourke, Martin"
-
1
Vasoactivity of AG014699, a Clinically Active Small Molecule Inhibitor of Poly(ADP-ribose) Polymerase: a Contributory Factor to Chemopotentiation In vivo?
Published in Clinical cancer research (01-10-2009)“…Purpose: Poly(ADP-ribose) polymerase (PARP) plays an important role in DNA repair, and PARP inhibitors can enhance the activity of DNA-damaging agents in vitro…”
Get full text
Journal Article -
2
P3 SAR exploration of biphenyl carbamate based Legumain inhibitors
Published in Bioorganic & medicinal chemistry letters (01-06-2014)“…This Letter describes the further development and SAR exploration of a novel series of Legumain inhibitors. Based upon a previously identified Legumain…”
Get full text
Journal Article -
3
FKBPL and Peptide Derivatives: Novel Biological Agents that Inhibit Angiogenesis by a CD44-Dependent Mechanism
Published in Clinical cancer research (01-03-2011)“…Antiangiogenic therapies can be an important adjunct to the management of many malignancies. Here we investigated a novel protein, FKBPL, and peptide…”
Get full text
Journal Article -
4
-
5
Identification and functional analysis of a novel bradykinin inhibitory peptide in the venoms of New World Crotalinae pit vipers
Published in Biochemical and biophysical research communications (23-12-2005)“…A novel undecapeptide has been isolated and structurally characterized from the venoms of three species of New World pit vipers from the subfamily, Crotalinae…”
Get full text
Journal Article -
6
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4
Published in BMC cancer (11-04-2019)“…Optimising breast cancer treatment remains a challenge. Resistance to therapy is a major problem in both ER- and ER+ breast cancer. Tumour recurrence after…”
Get full text
Journal Article -
7
Evaluation of the Antiangiogenic Potential of AQ4N
Published in Clinical cancer research (01-03-2008)“…Purpose: A number of cytotoxic chemotherapy agents tested at low concentrations show antiangiogenic properties with limited cytotoxicity, e.g.,…”
Get full text
Journal Article -
8
Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development
Published in Scientific reports (20-09-2022)“…The serine/threonine protein kinase AKT plays a pivotal role within the PI3K pathway in regulating cellular proliferation and apoptotic cellular functions, and…”
Get full text
Journal Article -
9
Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself
Published in PloS one (17-02-2015)“…Therapeutic inhibition of poly(ADP-ribose) polymerase (PARP), as monotherapy or to supplement the potencies of other agents, is a promising strategy in cancer…”
Get full text
Journal Article -
10
Bradykinin-related peptides, including a novel structural variant, (Val 1)-bradykinin, from the skin secretion of Guenther's frog, Hylarana guentheri and their molecular precursors
Published in Peptides (New York, N.Y. : 1980) (01-04-2007)“…Multiple bradykinin-related peptides including a novel bradykinin structural variant, (Val 1)-bradykinin, have been identified from the defensive skin…”
Get full text
Journal Article -
11
Bradykinins and their precursor cDNAs from the skin of the fire-bellied toad ( Bombina orientalis)
Published in Peptides (New York, N.Y. : 1980) (01-09-2002)“…Bradykinin and (Thr 6)-bradykinin have been identified in the defensive skin secretion of the fire-bellied toad, Bombina orientalis. The homologous cDNAs for…”
Get full text
Journal Article -
12
Abstract 1730: A translational platform using primary human immune cells in vitro, syngeneic and humanized models in vivo to support and advance immuno-oncology drug discovery
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Charles River Laboratories (CRL) has established a powerful translational immuno-oncology platform with the capability of progressing biologics or…”
Get full text
Journal Article -
13
Helokinestatin: A new bradykinin B 2 receptor antagonist decapeptide from lizard venom
Published in Peptides (New York, N.Y. : 1980) (2008)“…Synthetic bradykinin antagonist peptides/peptoids have been powerful tools for delineating the roles of kinins in both normal physiology and in pathological…”
Get full text
Journal Article -
14
The effect of nicotinamide on spontaneous and induced activity in smooth and skeletal muscle
Published in Radiotherapy and oncology (01-08-2000)“…Background and purpose: Nicotinamide (NA) is currently undergoing clinical trials as a tumour radiosensitizer. The dose that can be administered is currently…”
Get full text
Journal Article -
15
Helokinestatin : A new bradykinin B2 receptor antagonist decapeptide from lizard venom
Published in Peptides (New York, N.Y. : 1980) (2008)“…Synthetic bradykinin antagonist peptides/peptoids have been powerful tools for delineating the roles of kinins in both normal physiology and in pathological…”
Get full text
Journal Article -
16
The complex array of bradykinin-related peptides (BRPs) in the peptidome of pickerel frog ( Rana palustris) skin secretion is the product of transcriptional economy
Published in Peptides (New York, N.Y. : 1980) (01-06-2007)“…Previous peptidomic analyses of the defensive skin secretion from the North American pickerel frog, Rana palustris, have established the presence of canonical…”
Get full text
Journal Article -
17
FKBPL Regulates Estrogen Receptor Signaling and Determines Response to Endocrine Therapy
Published in Cancer research (Chicago, Ill.) (01-02-2010)“…The HSP90 chaperone and immunophilin FKBPL is an estrogen-responsive gene that interacts with estogen receptor alpha (ERalpha) and regulates its levels. In…”
Get full text
Journal Article -
18
A Novel FK506-Like Binding Protein Interacts with the Glucocorticoid Receptor and Regulates Steroid Receptor Signaling
Published in Endocrinology (Philadelphia) (01-11-2008)“…FKBP-like (FKBPL) protein is a novel immunophilin-like protein that plays a role in the cellular stress response. Its three tetratricopeptide repeat motifs are…”
Get full text
Journal Article -
19
Abstract 3288: The anti-tumour efficacy of the novel peptide inhibitor of angiogenesis ALM-201
Published in Cancer research (Chicago, Ill.) (15-04-2011)“…Abstract Neovascularization is critical to tumour growth and metastasis and this has led to the development of a number of marketed anti-angiogenic agents…”
Get full text
Journal Article -
20
Pericytes influence endothelial cell growth characteristics : Role of plasminogen activator inhibitor type 1 (PAI-1)
Published in Cardiovascular research (2006)“…Pericytes, located in close proximity to the underlying endothelium, form an integral component of the microvasculature. These cells are intimately involved in…”
Get full text
Journal Article